In a big move, Bluejay Capital Partners has teamed up with Quality Life Science Logistics & Transportation (QLS). This isn't just any old partnership. It's a recapitalization deal that's set to shake things up in the world of cold chain logistics. QLS, based in Coopersville, Michigan, is no small p
Scientists have found a clever new way to make special molecules called α-CF3 allylamines. These molecules are super important in making medicines, pesticides, and other useful materials. The problem was that making them wasn't easy or efficient. The new method uses a special kind of chemistry call
Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp
Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s
Scientists have found a clever way to make special molecules using light. They used a simple method that doesn't need metals or strong chemicals. Instead, they used a special compound called trifluoromethyl thianthrenium triflate, or TT-CF3+OTf-, which is easy to make and stable in air. This method
Novartis, a Swiss pharmaceutical giant, has just opened a new manufacturing plant in Carlsbad, California. This facility is part of a bigger plan to invest $23 billion in the United States over the next five years. The focus of this new plant is on making cancer drugs, specifically for a treatment c
In the world of heart health, a new player has emerged. This player is called zalunfiban. It's a special kind of medicine. It's designed to help people who are having a certain type of heart attack. This type is known as ST-segment elevation myocardial infarction, or STEMI for short. Zalunfiban is
Yeasts are tiny powerhouses. They've been helping humans make bread, beer, and wine for ages. Now, scientists are using them to make medicines too. One such yeast, Kluyveromyces lactis, is known for its work in the dairy industry. But now, it's being used in a new way. Scientists have developed a me
Texas has taken a bold step by suing Tylenol's maker, Kenvue, and its former owner, Johnson & Johnson. The lawsuit claims these companies misled the public about Tylenol's safety during pregnancy. The main concern? A possible link between Tylenol and developmental issues like autism and ADHD. The l
The 15th European Immunogenicity Platform Open Symposium took place in Lisbon from February 22-24, 2024. This event brought together professionals from various fields, including industry, regulatory bodies, and academia. They gathered to discuss the challenges posed by the immune response to bioph
